GlaxoSmithKline (GSK) is in the news again making headlines after having to settle another major lawsuit bringing the latest total to over $9.1 billion since 2003.

This time, it is due to GSK’s product Pandemrix, which was the swine flu vaccine forced upon the public during the pandemic of 2009 (which is argued by some to have been fake). As the victims are being compensated in the U.K., the same neurological mechanisms that damaged the children in the lawsuit are still potentially at work in the confirmed excitotoxicity that takes place after many vaccine injections.  Read more…